Average Co-Inventor Count = 3.61
ph-index = 16
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck + Co., Inc. (31 from 4,770 patents)
2. Other (2 from 832,966 patents)
3. Merck Sharp + Dohme Corp. (1 from 2,405 patents)
34 patents:
1. 7745452 - Quinazolinone T-type calcium channel antagonists
2. 7452893 - 4-cycloakylaminopyrazolo pyrimidine NMDA/NR2B antagonists
3. 7279487 - Hydroxynaphthyridinone carboxamides useful as HIV integrase inhibitors
4. 6939964 - Crystal forms of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
5. 6921759 - Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors
6. 6919351 - Aza-and polyaza-naphthalenyl-carboxamides useful as HIV integrase inhibitors
7. 6841558 - Aza-and polyaza-naphthalenyl carboxamides useful as HIV intergrase inhibitors
8. 6639071 - Crystal Forms of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
9. 6380249 - HIV integrase inhibitors
10. 6306891 - HIV integrase inhibitors
11. 6262055 - HIV integrase inhibitors
12. 6093737 - Inhibitors of farnesyl-protein transferase
13. 6080870 - Biaryl substituted imidazole compounds useful as farnesyl-protein
14. 6077853 - Inhibitors of farnesyl-protein transferase
15. 5990107 - Fibrinogen receptor antagonist prodrugs